Birth outcomes in women with inflammatory bowel disease: Effects of disease activity and drug exposure

Inflammatory Bowel Diseases

Volumn 20, Issue 6, 2014, Pages 1091-1098

  Bröms, Gabriella ^a   Granath, Fredrik ^a   Linder, Marie ^a   Stephansson, Olof ^a,b   Elmberg, Maria ^a   Kieler, Helle ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Crohn's disease; Pregnancy; Ulcerative colitis

Indexed keywords

CORTICOSTEROID; MERCAPTOPURINE;

ADULT; ADVERSE OUTCOME; APGAR SCORE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE EXACERBATION; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; INFLAMMATORY BOWEL DISEASE; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; SMALL FOR DATE INFANT; STILLBIRTH; ULCERATIVE COLITIS; COLITIS, ULCERATIVE; COMORBIDITY; EPIDEMIOLOGY; FETAL GROWTH RETARDATION; NEWBORN; PREGNANCY; PREMATURE BIRTH; REGISTER; RISK FACTOR; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; COLITIS, ULCERATIVE; COMORBIDITY; CROHN DISEASE; FEMALE; FETAL GROWTH RETARDATION; HUMANS; HYPOGLYCEMIA; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; REGISTRIES; RISK FACTORS; STILLBIRTH; YOUNG ADULT;

EID: 84902130328     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000060     Document Type: Article

References (30)

1. Molodecky NA, Soon IS, Rabi D.M., et al Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012; 142: 46e42-54e42; quiz e30.
2. Mountifield R, Bampton P, Prosser R., et al Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Inflamm Bowel Dis. 2009; 15: 720-725.
3. Selinger CP, Eaden J, Selby W., et al Inflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views. J Crohns Colitis. 2013; 7:e206-e213.
4. Norgard B, Fonager K, Sorensen H.T., et al Birth outcomes of women with ulcerative colitis: a nationwide Danish cohort study. Am J Gastroenterol. 2000; 95: 3165-3170.
5. Cornish J, Tan E, Teare J., et al A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut. 2007; 56: 830-837. (Pubitemid 46854200)
6. Dominitz JA, Young JC, Boyko EJ Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol. 2002; 97: 641-648. (Pubitemid 34245893)
7. Kornfeld D, Cnattingius S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease-a population-based cohort study. Am J Obstet Gynecol. 1997; 177: 942-946. (Pubitemid 27516071)
8. Stephansson O, Larsson H, Pedersen L., et al Crohn's disease is a risk factor for preterm birth. Clin Gastroenterol Hepatol. 2010; 8: 509-515.
9. Stephansson O, Larsson H, Pedersen L., et al Congenital abnormalities and other birth outcomes in children born to women with ulcerative colitis in Denmark and Sweden. Inflamm Bowel Dis. 2011; 17: 795-801.
10. Mahadevan U, Sandborn WJ, Li D.K., et al Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology. 2007; 133: 1106-1112. (Pubitemid 47494456)
11. Bortoli A, Saibeni S, Tatarella M., et al Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case-control study. J Gastroenterol Hepatol. 2007; 22: 542-549. (Pubitemid 46434983)
12. Smith GC, Fretts RC Stillbirth. Lancet. 2007; 370: 1715-1725. (Pubitemid 350100790)
13. Cousens S, Blencowe H, Stanton C., et al National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis. Lancet. 2011; 377: 1319-1330.
14. Saigal S, Doyle LW An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet. 2008; 371: 261-269.
15. Nguyen GC, Boudreau H, Harris M.L., et al Outcomes of obstetric hos-pitalizations among women with inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol. 2009; 7: 329-334.
16. Goldenberg RL, Hauth JC, Andrews WW Intrauterine infection and preterm delivery. N Engl J Med. 2000; 342: 1500-1507. (Pubitemid 30318275)
17. Romero R, Espinoza J, Goncalves L.F., et al Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med. 2006; 11: 317-326. (Pubitemid 44038705)
18. Nasef NA, Ferguson LR Inflammatory bowel disease and pregnancy: overlapping pathways. Transl Res. 2012; 160: 65-83.
19. Longo S, Bollani L, Decembrino L., et al Short-term and long-term sequelae in intrauterine growth retardation (IUGR). J Matern Fetal Neonatal Med. 2013; 26: 222-225.
20. Garg M, Devaskar SU Glucose metabolism in the late preterm infant. Clin Perinatol. 2006; 33: 853-870; abstract ix-x. (Pubitemid 44834648)
21. Engineer N, Kumar S. Perinatal variables and neonatal outcomes in severely growth restricted preterm fetuses. Acta Obstet Gynecol Scand. 2010; 89: 1174-1181.
22. Francella A, Dyan A, Bodian C., et al The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology. 2003; 124: 9-17. (Pubitemid 36055333)
23. Norgard B, Pedersen L, Fonager K., et al Azathioprine, mercaptopurine and birth outcome: a population-based cohort study. Aliment Pharmacol Ther. 2003; 17: 827-834. (Pubitemid 36418880)
24. Akbari M, Shah S, Velayos F.S., et al Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013; 19: 15-22.
25. Coelho J, Beaugerie L, Colombel J.F., et al Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study. Gut. 2011; 60: 198-203.
26. Wettermark B, Hammar N, Fored C.M., et al The new Swedish Prescribed Drug Register-opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007; 16: 726-735. (Pubitemid 47180362)
27. Cnattingius S, Ericson A, Gunnarskog J., et al A quality study of a medical birth registry. Scand J Soc Med. 1990; 18: 143-148. (Pubitemid 20183321)
28. Ludvigsson JF, Andersson E, Ekbom A., et al External review and validation of the Swedish national inpatient register. BMC Public Health. 2011; 11: 450.
29. Norgard B, Pedersen L, Christensen L.A., et al Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol. 2007; 102: 1406-1413. (Pubitemid 46976292)
30. Stephansson O, Granath F, Svensson T., et al Drug use during pregnancy in Sweden-assessed by the Prescribed Drug Register and the Medical Birth Register. Clin Epidemiol. 2011; 3: 43-50.